Calprotectin Testing Market: Overview
Reports and Insights predict that the global calprotectin testing market is expected to grow at a CAGR of 6.4% during the forecast period from 2022 to 2030. Furthermore, the total value of the global calprotectin testing market is slated to reach US$ 326.3 Mn by 2030, rising from US$ 198.3 Mn in 2022.
The degree of intestinal inflammation is determined by a fecal test called calprotectin. Demand for calprotectin testing is booming due to the growing prevalence of cancer and irritable bowel syndrome globally.
The emphasis on at-home testing, which has several benefits including ease of use and diagnosis, is also boosting the sector. These tests can be easily performed in between patient visits if the issue is getting worse and more regular testing is required.
Likewise, the prevalence of IBD and irritable bowel syndrome (IBS) is escalating, which is driving up demand for calprotectin testing and growth in the use of IBD remote monitoring. Active diagnostic testing is therefore more essential for an early diagnosis and successful therapy as a result.
Market Report Outlook:
This report on the global calprotectin testing market aims to discuss market dynamics, including market drivers, potential threats and challenges to the market, global calprotectin testing market opportunities for the major players, global calprotectin testing market trends, market segmentation outlook, regional outlook, global calprotectin testing market size, market forecast, market share, as well as the major players operating in the global calprotectin testing market.
Calprotectin Testing Market: Dynamics
As inflammatory bowel illness becomes more common, the demand for calprotectin testing is anticipated to increase (IBD). Chronic, relapsing, and inflammatory gastric disease is inflammatory bowel disease. The prevalence of Crohn's disease (CD) and ulcerative colitis (UC) is escalating, which will increase market demand. For illustration, according to a 2018 study by the Crohn's and Colitis Foundation of Canada, approximately 27,000 people were living with IBD. By 2030, this figure is predicted to rise to 400,000, representing a 50% increase in the disease's prevalence. According to a different study that was written up in the Journal of Gastroenterology & Hepatology, there were around 6.8 million IBD cases reported worldwide in 2017. The study also concluded that there will be an increase in IBD cases worldwide in the coming years.
Increased calprotectin levels could be a sign of inflammation in the gastrointestinal tract. High levels of calprotectin, however, may not always indicate the presence of IBD. It thus hinders the market from growing during the anticipated period.
These applications for the development of prediction models, precision medicine, epidemiology models, and drug discovery will be advantageous for IBD. Additionally, the utilization of big data in calprotectin testing will create new opportunities for market growth.
Calprotectin Testing Market: Regional Outlook
Based on a geographical study, the market for calprotectin testing is segmented into North America, Latin America, Europe, Asia Pacific, the Middle East & Africa, and the Rest of the World.
Throughout the projection period, it is expected that the U.S. will dominate the North American calprotectin testing market, and this trend is likely to continue.
The demand for calprotectin testing in the UK is being driven by a rise in IBS cases.
Due to an increasing emphasis on the home testing system, China, which currently has the largest share of the East Asian calprotectin testing market, is predicted to grow quickly over the forecast period.
India currently holds a dominant position in the South Asian calprotectin testing market, and due to advancements in its diagnostic infrastructure, it is predicted that India will expand at a robust CAGR throughout the projection period.
Calprotectin Testing Market: Key Players
The prime competitor of the global calprotectin testing market are as follows; Abbexa, AccuBio Tech Co., Ltd., Actim Oy, American Laboratory Products Company, Ltd., Beckman Coulter Inc., Biohit Oyj, Boditech Med Inc., BUHLMANN Laboratories AG, Calpro AS, CerTest Biotec S.L., DiaSorin, DIAsource ImmunoAssays S.A, EagleBio, Elabscience Biotechnology Inc, Epitope Diagnostics, Inc.EUROIMMUN Medizinische Labordiagnostika AG, Hangzhou Biotest Biotech Co., Ltd, R-Biopharm AG., Screen Italia Srl., Thermo Fisher Scientific, and Vitassay Healthcare, S.L.U. amongst other.
Calprotectin Testing Market: Segmentation Outlook
Data for growth projections and estimates are included in this study for the Test Kits segment (Calprotectin ELISA Test Kits, and Calprotectin Rapid Testing Kits); for the Sample segment (Stool, Blood Serum/Plasma, and Other Biological Samples); for the indication segment (Irritable Bowel Syndrome (IBS), Ulcerative Colitis, Crohn's Disease, and Colorectal Cancer); for the End-User segment (Hospitals, Diagnostic Laboratories, and Specialty Clinics).
Reports and Insights
For Sales Query: [email protected]
For New Topics & Other Info: [email protected]